From: Disparities in the surgical staging of high-grade endometrial cancer in the United States
Overall | Black | White | Other | p-values | |
---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | ||
Total | 42,973 (100)a | 5,285 (12.2) | 35,694 (76.1) | 1,417 (3.3) | |
Age at diagnosis | |||||
Mean (SD) | 66.0 (11.5) | 65.7 (11.7) | 66.2 (11.7) | 61.5 (11.6) | <0.001 |
Income | |||||
< $38,000 | 7,708 (17.9) | 2,352 (44.5) | 5,119 (14.3) | 167 (11.8) | <0.001 |
$38,000–$47,999 | 9,814 (22.9) | 1,175 (22.2) | 8,304 (23.3) | 216 (15.2) | |
$48,000–$62,999 | 11,218 (26.1) | 921 (17.4) | 9,747 (27.3) | 375 (26.5) | |
≥ $63,000 | 13,192 (30.7) | 707 (13.4) | 11,668 (32.7) | 627 (44.2) | |
Unknown | 1,041 (2.4) | ||||
Insurance status | |||||
Uninsured | 1,418 (3.3) | 256 (4.8) | 1,060 (3.0) | 81 (5.7) | <0.001 |
Private Insurance | 17,582 (40.9) | 1,807 (34.2) | 14,845 (40.6) | 683 (48.2) | |
Medicaid and Medicare | 22,750 (52.9) | 3,081 (58.3) | 18,823 (52.7) | 578 (40.8) | |
Other | 282 (0.7) | 30 (0.6) | 218 (0.6) | 33 (2.3) | |
Unknown | 941 (2.2) | ||||
Educationb | |||||
≥ 21% | 7,196 (16.7) | 1,928 (36.5) | 4,881 (13.7) | 318 (22.4) | <0.001 |
13–20% | 10,792 (25.1) | 1,923 (36.4) | 8,393 (23.5) | 344 (24.3) | |
7.0–12.9% | 13,867 (32.3) | 933 (17.7) | 12,314 (34.5) | 413 (29.1) | |
< 7.0% | 10,107 (23.5) | 373 (7.1) | 9,277 (26.0) | 310 (21.9) | |
Unknown | 1,011 (2.4) | ||||
Charlson-Deyo Score | |||||
0 | 24,653 (57.4) | 2,858 (54.1) | 20,540 (57.5) | 890 (62.8) | <0.001 |
≥ 1 | 8,128 (18.9) | 1,307 (24.7) | 6,465 (18.1) | 258 (18.2) | |
Unknown | 10,192 (23.7) | ||||
Histology | |||||
Uterine papillary Serous | 8,238 (19.1) | 1,506 (28.5) | 6,413 (18.0) | 211 (14.9) | <0.001 |
Clear cell | 3,631 (8.5) | 576 (10.9) | 2,873 (8.0) | 134 (9.5) | |
Grade 3 endometrioid | 31,104 (72.4) | 3,203 (60.6) | 26,408 (74.0) | 1,072 (75.6) | |
FIGO Stage | |||||
I | 24,052 (55.9) | 2,622 (49.6) | 20,348 (57.0) | 756 (53.4) | <0.001 |
II | 4,888 (11.4) | 764 (14.5) | 3,911 (11.0) | 152 (10.7) | |
III | 14,033 (32.7) | 1,899 (35.9) | 11,435 (32.0) | 509 (35.9) | |
Lymph node samplingc | |||||
Yes | 35,158 (81.8) | 4,265 (80.7) | 29,211 (81.8) | 1,214 (85.7) | <0.001 |
No | 7,815 (18.2) | 1,020 (19.3) | 6,483 (18.2) | 203 (14.3) | |
Treatment center type | |||||
Community Cancer Program | 2,647 (6.2) | 269 (5.1) | 2,258 (6.3) | 108 (7.6) | <0.001 |
Comprehensive Community Cancer Program | 22,272 (51.8) | 2,225 (42.1) | 19,191 (53.8) | 621 (43.8) | |
Academic/ Research Program | 18,054 (42.0) | 2,791 (52.8) | 14,245 (39.9) | 688 (48.6) | |
Hospital surgical volumed | |||||
Very–high | 30,518 (71.0) | 3,880 (73.4) | 25,146 (70.5) | 1,006 (71.0) | <0.001 |
Moderately–high | 7,998 (18.6) | 926 (17.5) | 6,709 (18.8) | 296 (20.9) | |
Intermediate | 3,272 (7.6) | 379 (7.2) | 2,796 (7.8) | 83 (5.9) | |
Low | 1,185 (2.8) | 100 (1.9) | 1,043 (2.9) | 32 (2.2) | |
Distance to care | |||||
≤ 30 miles | 31,645 (73.6) | 4,246 (80.3) | 25,884 (72.5) | 1,152 (81.3) | <0.001 |
> 30 miles | 10,366 (24.1) | 913 (17.3) | 9,025 (25.3) | 234 (16.5) | |
Unknown | 962 (2.3) |